"He has broken the mould for strategic behaviour and thinking by anyone in the life sciences in Australia. He has had at least four new investigational new drug applications passed through the FDA [US Food and Drug Administration]. No other Australian company has done that and had that success rate. That is a sign of the capability within the company, and of its consultants.”It typically takes 12 to 15 years to take any new medicine from the lab bench to the chemist’s shelf."
By David Blake, of Bioshares
Ann: Mesoblast Completes Placement and Entitlement Offer, page-154
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.19 |
Change
-0.063(4.98%) |
Mkt cap ! $1.367B | |||
| Open | High | Low | Value | Volume |
| $1.22 | $1.23 | $1.18 | $4.995M | 4.161M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 54650 | $1.19 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.20 | 59696 | 21 |
View Market Depth
| Last trade - 12.51pm 25/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |